CVS HEALTH CORPORATION REPORTS THIRD QUARTER 2024 RESULTS
Portfolio Pulse from
CVS Health Corporation reported a 6.3% increase in third-quarter revenues to $95.4 billion. The GAAP diluted EPS was $0.07, and Adjusted EPS was $1.09, both impacted by a $1.1 billion charge in the Health Care Benefits segment. Year-to-date cash flow from operations reached $7.2 billion.
November 06, 2024 | 11:45 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
CVS Health's Q3 2024 results show a 6.3% revenue increase to $95.4 billion. EPS figures were affected by a $1.1 billion charge in the Health Care Benefits segment. The company generated $7.2 billion in cash flow from operations year-to-date.
The revenue increase is positive, but the EPS was negatively impacted by a significant charge, which may concern investors. The strong cash flow is a positive indicator, balancing the mixed EPS results.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100